Developing biomarkers for the early detection of age related diseases

arrow icon

Welcome to Age Labs

Age Labs is a Norwegian life science company that discovers, develops and commercializes diagnostic tests for the early detection of age-related diseases. Our pipeline includes a test for early detection of rheumatoid arthritis, a biological age predictor and a test predicting the severity of COVID-19 infection. Our service includes developing biomarkers for use in clinical trials and  studying epigenetic drug effects.

Scientist stood in a laboratory

Our Service

Age Labs provides biomarker development and comprehensive reports on epigenetic drug effects for use in clinical trials.

Our main customers are companies from the pharmaceutical and nutraceutical industry.


R&D Pipeline

By using advanced machine learning on epigenetic datasets from biobanks, we develop biomarkers for the early detection of diseases.

Our first diagnostic candidate is a test for the early detection of rheumatoid arthritis.

We have several R&D projects in collaboration with pharma companies and public institutions in Norway.

Liquid being poured into test tubes

For a quote